Abstract
Polyamidoamine (PAMAM) dendrimer has received much attention as an alternative to polyethylenimine (PEI) for gene delivery due to the relatively low cytotoxicity. In general, low generational PAMAM dendrimers have better biocompatibility than high generational dendrimers but suffer reduced transfection efficiency. Transfection efficiency can be improved by the modification of the polymer with nuclear localization signal (NLS) peptides. In this study, we modified low generational cystamine core PAMAM dendrimers (cPAMAM, generation 0, 1 and 2) with a lactoferrin-derived nuclear localization signal (NLS) peptide and evaluated transfection efficiency and cytotoxicity as a function of the number of conjugated NLS peptides using NIH 3T3, MCF-7 and human dermal fibroblasts (HDFs). The transfection efficiency of NLS-modified cPAMAM G2 was the highest among the cPAMAM derivatives and similar or higher than PEI 25 kDa. The cytotoxicity of cPAMAM derivatives was generation-dependent and significantly lower than PEI 25 kDa. Our study indicates that cPAMAM G2 conjugated with NLS is a promising candidate for gene delivery applications.
Similar content being viewed by others
References
M. R. Cring and V. C. Sheffield, Gene Ther., 29, 3 (2020).
M. Ramamoorth and A. Narvekar, J. Clin. Diagn., 9(1), GE01 (2015).
Y. Wang, K. F. Bruggeman, S. Franks, V. Gautam, S. I. Hodgetts, A. R. Harvey, R. J. Williams and D. R. Nisbet, Adv. Healthc. Mater., 10(1), 2001238 (2021).
E. Ayuso, Mol. Ther. Methods Clin. Dev., 3, 15049 (2016).
P. Wu, H. Chen, R. Jin, T. Weng, J. K. Ho, C. You, L. Zhang, X. Wang and C. Han, J. Transl. Med., 16(1), 1 (2018).
C. Rinoldi, S. Zargarian, S. P. Nakielski, X. Li, A. Liguori, F. Petronella, D. Presutti, Q. Wang, M. Costantini and L. De Sio, Small Method., 5(9), 2100402 (2021).
L. Zhu and R. I. Mahato, Expert Opin. Drug Deliv., 7(10), 1209 (2010).
Y. Cheng, R. C. Yumul and S. H. Pun, Angew. Chem. Int. Ed., 55(39), 12013 (2016).
Y. S. Lee and S. W. Kim, J. Control. Release, 190, 424 (2014).
Y. Liu, J. Li, K. Shao, R. Huang, L. Ye, J. Lou and C. Jiang, Biomaterials, 31(19), 5246 (2010).
T. H. Kim, J. E. Ihm, Y. J. Choi, J. W. Nah and C. S. Cho, J. Control. Release, 93(3), 389 (2003).
J. M. Benns, J.-S. Choi, R. I. Mahato, J.-S. Park and S. W. Kim, Bioconjug. Chem., 11(5), 637 (2000).
U. Lächelt and E. Wagner, Chem. Rev., 115(19), 11043 (2015).
J. Lee, J. Jung, Y.-J. Kim, E. Lee and J. S. Choi, Int. J. Pharm., 459(1–2), 10 (2014).
K. Ma, M. X. Hu, Y. Qi, J. H. Zou, L. Y. Qiu, Y. Jin, X.-Y. Ying and H. Y. Sun, Biomaterials, 30(30), 6109 (2009).
Y.M. Bae, H. Choi, S. Lee, S.H. Kang, Y.T. Kim, K. Nam, J.S. Park, M. Lee and J. S. Choi, Bioconjug. Chem., 18(6), 2029 (2007).
J. S. Choi, K. S. Ko, J. S. Park, Y. H. Kim, S. W. Kim and M. Lee, Int. J. Pharm., 320(1–2), 171 (2006).
T. Boulikas, Crit. Rev. Eukaryot. Gene Expr., 3(3), 193 (1993).
N. T. Pourianazar, P. Mutlu and U. Gunduz, J. Nanoparticle Res., 16(4), 1 (2014).
S. M. Moghimi, P. Symonds, J. C. Murray, A. C. Hunter, G. Debska and A. Szewczyk, Mol. Ther., 11(6), 990 (2005).
X. Li, S. Hao, A. Han, Y. Yang, G. Fang, J. Liu and S. Wang, J. Mater. Chem. B, 7(25), 4008 (2019).
R. Jevprasesphant, J. Penny, R. Jalal, D. Attwood, N. B. McKeown and A. D’emanuele, Int. J. Pharm, 252(1–2), 263 (2003).
J. Haensler and F. C. Szoka Jr., Bioconjug. Chem., 4(5), 372 (1993).
S. Kumari and A. K. Kondapi, Int. J. Biol. Macromol., 108, 401 (2018).
S. Penco, S. Scarfi, M. Giovine, G. Damonte, E. Millo, B. Villaggio, M. Passalacqua, M. Pozzolini, C. Garrè and U. Benatti, Biotechnol. Appl. Biochem., 34(3), 151 (2001).
J. Lee, S. Lee, Y. E. Kwon, Y. J. Kim and J. S. Choi, Macromole. Res., 27(4), 360 (2019).
L. T. Thuy, S. Mallick and J. S. Choi, Int. J. Pharm., 492(1–2), 233 (2015).
A. M. Wade and H. N. Tucker, J. Nutr. Biochem., 9(6), 315 (1998).
A. Mecke, S. Uppuluri, T. M. Sassanella, D. K. Lee, A. Ramamoorthy, J. R. Baker Jr., G. O. Bradford and M. M. B. Holl, Chem. Phys. Lipids, 132(1), 3 (2004).
A. J. Geall and I. S. Blagbrough, J. Pharm. Biomed., 22(5), 849 (2000).
H. Eliyahu, Y. Barenholz and A. Domb, Molecules, 10(1), 34 (2005).
B. D. Monnery, Biomacromolcules, 22(10), 4060 (2021).
T. Bus, A. Traeger and U. S. Schubert, J. Mater. Chem. B, 6(43), 6904 (2018).
S. Brunner, T. Sauer, S. Carotta, M. Cotten, M. Saltik and E. Wagner, Gene Ther., 7(5), 401 (2000).
A. Pantos, I. Tsogas and C. M. Paleos, Biochim. Biophys. Acta-Biomembr., 1778(4), 811 (2008).
N. Sakai, T. Takeuchi, S. Futaki and S. Matile, ChemBioChem, 6(1), 114 (2005).
H. Chang, J. Zhang, H. Wang, J. Lv and Y. Cheng, Biomacromolcules, 18(8), 2371 (2017).
F. Wang, K. Hu and Y. Cheng, Acta Biomater., 29, 94 (2016).
I. Tsogas, D. Tsiourvas, G. Nounesis and C. M. Paleos, Langmuir, 22(26), 11322 (2006).
J. S. Choi, K. Nam, J. Y. Park, J. B. Kim, J. K. Lee and J. S. Park, J. Control. Release, 99(3), 445 (2004).
N. Panté and M. Kann, J. Mol. Cell Biol., 13(2), 425 (2002).
P. C. Naha, M. Davoren, F. M. Lyng and H. Byrne, Toxicol. Appl. Pharmacol., 246(1–2), 91 (2010).
Acknowledgement
This research was sponsored by the U.S. National Science Foundation and was accomplished under the Grant No. OIA-1757371.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supporting Information
Additional information as noted in the text. This information is available via the Internet at http://www.springer.com/chemistry/journal/11814.
Electronic Supplementary Material
11814_2022_1293_MOESM1_ESM.pdf
Low generational cystamine core PAMAM derivatives modified with nuclear localization signal derived from lactoferrin as a gene carrier
Rights and permissions
About this article
Cite this article
Lee, J., Kwon, YE., Guim, H. et al. Low generational cystamine core PAMAM derivatives modified with nuclear localization signal derived from lactoferrin as a gene carrier. Korean J. Chem. Eng. 40, 379–389 (2023). https://doi.org/10.1007/s11814-022-1293-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11814-022-1293-y